Linkage of inflammatory bowel disease to human chromosome 6p

American Journal of Human Genetics

Volumn 65, Issue 6, 1999, Pages 1647-1655

  Hampe, Jochen ^a   Shaw, Sarah H ^b   Saiz, Robert ^b   Leysens, Nancy ^b   Lantermann, Annette ^a   Mascheretti, Silvia ^a   Lynch, Nicholas J ^a   MacPherson, Andrew J S ^c   Bridger, Stephen ^c   Van Deventer, Sander ^d   Stokkers, Pieter ^d   Morin, Phil ^b   Mirza, Mudassar M ^c   Forbes, Alastair ^e   Lennard Jones, John E ^e   Mathew, Christopher G ^c   Curran, Mark E ^b   Schreiber, Stefan ^a  

^a UNIVERSITY OF KIEL   (Germany)

^b Axys Pharmaceuticals Inc   (United States)

^c GUY S HOSPITAL   (United Kingdom)

^d ACADEMIC MEDICAL CENTER   (Netherlands)

^e ST MARK S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CHROMOSOME 6P; CROHN DISEASE; ENTERITIS; GENE LOCUS; GENETIC ASSOCIATION; GENETIC LINKAGE; GENETIC MARKER; GENETIC SUSCEPTIBILITY; HUMAN; PHENOTYPE; PRIORITY JOURNAL; ULCERATIVE COLITIS;

EID: 0033358520     PISSN: 00029297     EISSN: None     Source Type: Journal    
DOI: 10.1086/302677     Document Type: Article

References (55)

1. Becker KG, Simon RM, Bailey-Wilson JE, Freidlin B, Biddison WE, McFarland HF, Trent JM (1998) Clustering of non-major histocompatibility complex susceptibility candidate loci in human autoimmune diseases. Proc Natl Acad Sci USA 95:9979-9984
2. Biemond I, Burnham WR, D'Amaro J, Langman MJ (1986) HLA-A and -B antigens in inflammatory bowel disease. Gut 27:934-941
3. Bouma G, Crusius JB, Garcia-Gonzalez MA, Meijer BU, Hellemans HP, Hakvoort RJ, Schreuder GM, et al (1999) Genetic markers in clinically well defined patients with ulcerative colitis (UC). Clin Exp Immunol 115:294-300
4. Bouma G, Xia B, Crusius JB, Bioque G, Koutroubakis I, Von Blomberg BM, Meuwissen SG, et al (1996) Distribution of four polymorphisms in the tumour necrosis factor (TNF) genes in patients with inflammatory bowel disease (IBD). Clin Exp Immunol 103:391-396
5. Cho JH, Nicolae DL, Gold LH, Fields CT, LaBuda MC, Rohal PM, Pickles MR, et al (1998) Identification of novel susceptibility loci for inflammatory bowel disease on chromosomes 1p, 3q, and 4q: evidence for epistasis between 1p and IBD1. Proc Natl Acad Sci USA 95:7502-7507
6. Concannon P, Gogolin-Ewens KJ, Hinds DA, Wapelhorst B, Morrison VA, Stirling B, Mitra M, et al (1998) A second-generation screen of the human genome for susceptibility to insulin-dependent diabetes mellitus. Nat Genet 19:292-296
7. Curran ME, Lau KF, Hampe J, Schreiber S, Bridger S, Macpherson AJS, Cardon LR, et al (1998) Genetic analysis of inflammatory bowel disease in a large European cohort supports linkage to chromosomes 12 and 16. Gastroenterology 115:1066-1071
8. Delpre G, Kadish U, Gazit E, Joshua H, Zamir R (1980) HLA antigens in ulcerative colitis and Crohn's disease in Israel. Gastroenterology 78:1452-1457
9. Ferencik S, Lindemann M, Horsthemke B, Grosse-Wilde H (1992) A new restriction fragment length polymorphism of the human TNF-B gene detected by AspHI digest. Eur J Immunogenet 19:425-430
10. Forcione DG, Sands B, Isselbacher KJ, Rustgi A, Podolsky DK, Pillai S (1996) An increased risk of Crohn's disease in individuals who inherit the HLA class II DRB3 * 0301 allele. Proc Natl Acad Sci USA 93:5094-5098
11. Fujita K, Naito S, Okabe N, Yao T (1984) Immunological studies in Crohn's disease. I. Association with HLA systems in the Japanese. J Clin Lab Immunol 14:99-102
12. Gleeson MH, Walker JS, Wentzel J, Chapman JA, Harris R (1972) Human leucocyte antigens in Crohn's disease and ulcerative colitis. Gut 13:438-440
13. Hall J, Nanthakumar E (1997) Automated fluorescent genotyping. In: Boyle AL (ed) Current protocols in human genetics. Vol 2. John Wiley & Sons, New York, pp 2.8.1-2.8.19
14. Hamilton SR (1987) The differential diagnosis of idiopathic inflammatory disease by colorectal biopsy. Int J Colorectal Dis 2:113-117
15. Hampe J, Hermann B, Bridger S, MacPherson AJ, Mathew CG, Schreiber S (1998) The interferon-gamma gene as a positional and functional candidate gene for inflammatory bowel disease. Int J Colorectal Dis 13:260-263
16. Hampe J, Schreiber S, Shaw SH, Lau KF, Bridger S, Macpherson AJS, Cardon LR, et al (1999) A genomewide analysis provides evidence for novel linkages in inflammatory bowel disease in a large European cohort. Am J Hum Genet 64:808-816
17. Holland PM, Abramson RD, Watson R, Gelfand DH (1991) Detection of specific polymerase chain reaction product by utilizing the 5′-3′ exonuclease activity of Thermus aquaticus DNA polymerase. Proc Natl Acad Sci USA 88: 7276-7280
18. Hugot JP, Laurent-Puig P, Gower-Rousseau C, Caillat-Zucman S, Beaugerie L, Dupas JL, Van Gossum A, et al (1994) Linkage analyses of chromosome 6 loci, including HLA, in familial aggregations of Crohn disease. Am J Med Genet 52:207-213
19. Idury RM, Cardon LR (1997) A simple method for automated allele binning in microsatellite markers. Genome Res 7:1104-1109
20. Kroeger KM, Carville KS, Abraham LJ (1997) The - 308 tumor necrosis factor-alpha promoter polymorphism effects transcription. Mol Immunol 34:391-399
21. Kruglyak L, Lander ES (1995) Complete multipoint sib-pair analysis of qualitative and quantitative traits. Am J Hum Genet 57:439-454
22. _, (1996) Limits on fine mapping of complex traits. Am J Hum Genet 58:1092-1093
23. Lander E, Kruglyak L (1995) Genetic dissection of complex traits: guidelines for interpreting and reporting linkage results. Nat Genet 11:241-247
24. Lennard-Jones JE (1989) Classification of inflammatory bowel disease. Scand J Gastroenterol Suppl 170:2-6
25. Livak KJ, Flood SJ, Marmaro J, Giusti W, Deetz K (1995) Oligonucleotides with fluorescent dyes at oposite ends provide a quenched probe system useful for detecting PCR product and nucleic acid hybridization. PCR Methods Appl 4:357-362
26. Matise TC, Perlin M, Chakravarti A (1994) Automated construction of genetic linkage maps using an expert system (MultiMap): a human genome linkage map. Nat Genet 6: 384-390
27. McGuire W, Hill AVS, Allsopp CEM, Greenwood BM, Kwiatkowski D (1994) Variation in the TNF-alpha promoter region associated with susceptibility to cerebral malaria. Nature 371:508-510
28. Messer G, Spengler U, Jung MC, Honold G, Blomer K, Pape GR, Riethmuller G, et al (1991) Polymorphic structure of the tumor necrosis factor (TNF) locus: an Ncol polymorphism in the first intron of the human TNF-beta gene correlates with a variant amino acid in position 26 and a reduced level of TNF-beta production. J Exp Med 173:209-219
29. Nadel S, Newport MJ, Booy R, Levin M (1996) Variation in the tumor necrosis factor-alpha gene promoter region may be associated with death from meningococcal disease. J Infect Dis 174:878-880
30. Nair RP, Henseler T, Jenisch S, Stuart P, Bichakjian CK, Lenk W, Westphal E, et al (1997) Evidence for two psoriasis susceptibility loci (HLA and 17q) and two novel candidate regions (16q and 20p) by genome-wide scan. Hum Mol Genet 6:1349-1356
31. Nakajima A, Matsuhashi N, Kodama T, Yazaki Y, Takazoe M, Kimura A (1995) HLA-linked susceptibility and resistance genes in Crohn's disease. Gastroenterology 109: 1462-1467
32. Olavesen MG, Hampe J, Mirza MM, Saiz R, Lewis CM, Bridger S, Teare D, et al. Analysis of single nucleotide polymorphisms in the interleukin 4 receptor gene for association with inflammatory bowel disease. Immunogenetics (in press)
33. Partanen J, Koskimies S (1988) Low degree of DNA polymorphism in in the HLA-linked lymphotoxin (tumor necrosis factor beta) gene. Scand J Immunol 28:313-316
34. Perri F, Annese V, Piepoli A, Napolitano G, Lombardi G, Ciavarella G, Di Giorgio G, et al (1998) HLA antigens and pANCA define ulcerative colitis as a genetically heterogeneous disorder. Ital J Gastroenterol Hepatol 30:56-61
35. Plevy SE, Targan SR, Yang H, Fernandez D, Rotter JI, Toyoda H (1996) Tumor necrosis factor microsatellites define a Crohn's disease-associated haplotype on chromosome 6. Gastroenterology 110:1053-1060
36. Podolsky DK (1991) Inflammatory bowel disease (1). N Engl J Med 325:928-937
37. Probert CS, Jayanthi V, Rampton DS, Mayberry JF (1996) Epidemiology of inflammatory bowel disease in different ethnic and religious groups: limitations and aetiological clues. Int J Colorectal Dis 11:25-28
38. Purrmann J, Korsten S, Bertrams J, Miller B, Lapsien B, Munch H, Reis HE, et al (1985) HLA haplotype study in familial Crohn disease. Z Gastroenterol 23:432-437
39. Roussomoustakaki M, Satsangi J, Welsh K, Louis E, Fanning G, Targan S, Landers C, et al (1997) Genetic markers may predict disease behavior in patients with ulcerative colitis. Gastroenterology 112:1845-1853
40. Russell AS, Percy JS, Schlaut J, Sartor VE, Goodhart JM, Sherbaniuk RW, Kidd EG (1975) Transplantation antigens in Crohn's disease: linkage of associated ankylosing spondylitis with HL-Aw27. Am J Dig Dis 20:359-361
41. Satsangi J, Parkes M, Louis E, Hashimoto L, Kato N, Welsh K, Terwilliger JD, et al (1996a) Two stage genome-wide search in inflammatory bowel disease provides evidence for susceptibility loci on chromosomes 3, 7 and 12. Nat Genet 14:199-202
42. Satsangi J, Welsh KI, Bunce M, Julier C, Farrant JM, Bell JI, Jewell DP (1996b) Contribution of genes of the major histocompatibility complex to susceptibility and disease phenotype in inflammatory bowel disease. Lancet 347:1212-1217
43. Schreiber S, Nikolaus S, Hampe J, Hämling J, Koop I, Lochs H, Raedler A (1999) Tumor necrosis factor alpha and interleukin 1-beta in relapse of Crohn's disease. Lancet 353:459-461
44. Shivananda S, Lennard-Jones J, Logan R, Fear N, Price A, Carpenter L, van Blankenstein M (1996) Incidence of inflammatory bowel disease across Europe: is there a difference between north and south? results of the European Collaborative Study on Inflammatory Bowel Disease (EC-IBD). Gut 39:690-697
45. Silverberg MS, Steinhart AH, McLeod RS, Griffitths A, Mirea L, Bull SB, Greenberg GR, et al (1999) Evidence for linkage between Crohn's disease (CD) and a locus near the major histocompatibility complex (MHC) on chromosome 6 in a Canadian inflammatory bowel disease (IBD) population. Gastroenterology 116:A820
46. Smolen JS, Gangl A, Polterauer P, Menzel EJ, Mayr WR ( 1982) HLA antigens in inflammatory bowel disease. Gastroenterology 82:34-38
47. Targan SR, Hanauer SB, van Deventer SJ, Mayer L, Present DH, Braakman T, DeWoody KL, et al (1997) A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease: Crohn's Disease cA2 Study Group. N Engl J Med 337:1029-1035
48. Terwilliger JD (1995) A powerful likelihood method for the analysis of linkage disequilibrium between trait loci and one or more polymorphic marker loci. Am J Hum Genet 56:777-787
49. Toyoda H, Wang SJ, Yang HY, Redford A, Magalong D, Tyan D, McElree CK, et al (1993) Distinct associations of HLA class II genes with inflammatory bowel disease. Gastroenterology 104:741-748
50. Truelove SC, Pena AS (1976) Course and prognosis of Crohn's disease. Gut 17:192-201
51. Uyar FA, Imeryuz N, Saruhan-Direskeneli G, Ceken H, Ozdogan O, Sahin S, Tozun N (1998) The distribution of HLA-DRB alleles in ulcerative colitis patients in Turkey. Eur J Immunogenet 25:293-296
52. Van den Berg-Loonen EM, Dekker-Saeys BJ, Meuwissen SG, Nijenhuis LE, Engelfriet CP (1977) Histocompatibility antigens and other genetic markers in ankylosing spondylitis and inflammatory bowel diseases. J Immunogenet 4:167-175
53. Weissensteiner T, Lanchbury JS (1997) TNFB polymorphisms characterize three lineages of TNF region microsatellite haplotypes. Immunogenetics 47:6-16
54. Wilson AG, Symons JA, McDowell TL, McDevitt HO, Duff GW (1997) Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. Proc Natl Acad Sci USA 94:3195-3199
55. Yang H, Plevy SE, Taylor K, Tyan D, Fischel-Ghodsian N, McElree C, Targan SR, et al (1999) Linkage of Crohn's disease to the major histocompatibility complex region is detected by multiple non-parametric analyses. Gut 44: 519-526